Economic evaluation in clinical nephrology: part 2. Applying economic evaluations in clinical nephrology

Nephrology (Carlton). 2010 Aug;15(5):533-9. doi: 10.1111/j.1440-1797.2010.01356.x.

Abstract

Our previous article described the principles of conducting an economic evaluation for evidence-based medical decision making. This article provides some tips for reading, critically appraising and applying the findings of an economic evaluation in clinical practice.

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use*
  • Cost-Benefit Analysis
  • Drug Costs
  • Evidence-Based Medicine
  • Health Care Costs*
  • Health Services Research / economics*
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / economics*
  • Models, Economic
  • Nephrology / economics*
  • Patient Selection*
  • Risk Assessment
  • Treatment Outcome

Substances

  • Antineoplastic Agents